i-Matter: Investigating an mHealth texting tool for embedding patient-reported data into diabetes management

Brief description of study

This study has two phases that will be completed over the course of 5 years. Phase 1 consists of the following: (1) focus groups to adapt MJS DIABETES to the needs of providers and patients with type 2 diabetes (2) a workshop to integrate MJS DIABETES into the electronic health record system, the primary care practice and the lives of patients with type 2 diabetes; and (3) evaluate the usability of MJS DIABETES in order to optimize the tool's performance and workflow integration. Phase 2 consists of a practice-based randomized controlled trial designed to test the effect of MJS DIABETES versus usual care on reducing HbA1c levels, and changes in how well patients comply with their self-care behaviors, knowledge about their diabetes, how sure they can manage their diabetes, and the quality of communication with their provider. This is Phase 1 of the study which seeks to refine and test a technology-based patient-reported outcome (PRO) system called the Modern Journal System [MJS] DIABETES. MJS DIABETES is designed to include patients' perspective of their disease and functional status into the management of type 2 diabetes in primary care practices.

Clinical Study Identifier: s18-01044
ClinicalTrials.gov Identifier: NCT03652389
Principal Investigator: Antoinette Marie Schoenthaler.
Other Investigator: Devin Mann.

If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.